TIBSOVO (ivosidenib) 

SELF ADMINISTRATION

Indications for Prior Authorization:

  • Treatment of adult patients with relapsed or refractory Acute Myeloid Leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test

Patients must meet the following criteria for the indication(s) above:

  • Patient is 18 years of age or older, AND
  • Patient has a diagnosis of relapsed or refractory AML as confirmed by chart note documentation, AND
  • Patient is isocitrate dehydrogenase-1 (IDH1) mutation positive as confirmed by an FDA-approved test, AND
  • Prescribed by or in consultation with an oncologist, AND
  • Will not be used with strong CYP3A4 inducers, sensitive CYP3A4 substrates, and QT prolonging drugs (when possible)

Dosing:

  • 500mg once daily

Approval:

  • 1 year

Last review date: June 3, 2019

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone